Takeda's colitis med Entyvio wins European OK on heels of FDA's approval

Japan's Takeda Pharmaceutical nabbed European approval for its treatment for ulcerative colitis and Crohn's disease, Entyvio, after winning the FDA's blessing last week. Report

Suggested Articles

A self-proclaimed former employee at Novartis’ Beijing office accused the Swiss drugmaker of expensing fake academic events to offer kickbacks to doctors.

Novo Nordisk just won an FDA approval that could help it stand out in the crowded—and competitive—basal insulin category.

Pfizer is training pharmacists in the U.K. to handle over-the-counter Viagra.